enteromedics.com

Welcome to EnteroMedics

Is the developer of vBloc. Neurometabolic therapy, delivered by a pacemaker-like device called the Maestro. Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc. Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals.

http://www.enteromedics.com/

OVERVIEW OF enteromedics.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

19

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR ENTEROMEDICS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

September

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 2.3 out of 5 with 3 reviews

5 star

1

4 star

0

3 star

0

2 star

0

1 star

2

Hey there! Start your review of enteromedics.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT ENTEROMEDICS.COM

EnteroMedics Inc.

EMI Administrator

2800 ●●●●●on Rd

Ros●●●lle , MN, 55113

US

1.65●●●●3003

em●●●●@enteromedics.com

View this contact

EnteroMedics Inc.

EMI Administrator

2800 ●●●●●on Rd

Ros●●●lle , MN, 55113

US

1.65●●●●3003

em●●●●@enteromedics.com

View this contact

EnteroMedics Inc.

Entero Ops

2800 ●●●●●on Rd

Ros●●●lle , MN, 55113

US

1.65●●●●3003

em●●●●@enteromedics.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2003 October 22
UPDATED: 2012 March 08
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

20

YEARS
6

MONTHS
22

DAYS

NAME SERVERS

1: ns1.atomic-colo.com
2: ns2.atomic-colo.com
3: ns3.atomic-colo.com

REGISTRAR

DNC HOLDINGS, INC.

WHOIS : whois.directnic.com

REFERRED : http://www.directnic.com

CONTENT

PAGES IN
THIS WEBSITE

19

SSL

EXTERNAL LINKS

118

SITE IP

216.119.123.143

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Welcome to EnteroMedics | enteromedics.com Reviews

<META> DESCRIPTION

Is the developer of vBloc. Neurometabolic therapy, delivered by a pacemaker-like device called the Maestro. Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc. Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals.

<META> KEYWORDS

1 sitemap

2 enteromedics

3 nasdaq etrm

4 more news

5 vbloc

6 learn more

7 legal

8 about us

9 overview

10 our mission

CONTENT

Page content here

KEYWORDS ON PAGE

sitemap,enteromedics,nasdaq etrm,more news,vbloc,learn more,legal,about us,overview,our mission,management,board of directors,international,about vbloc therapy,vbloc maestro system,obesity,clinical experience,diabetes,cardiovascular disease,publications

SERVER

nginx

POWERED BY

PHP/7.0.28,PleskLin

CONTENT-TYPE

windows-1252

GOOGLE PREVIEW

Welcome to EnteroMedics | enteromedics.com Reviews

https://enteromedics.com

Is the developer of vBloc. Neurometabolic therapy, delivered by a pacemaker-like device called the Maestro. Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc. Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals.

SUBDOMAINS

ir.enteromedics.com

EnteroMedics® Inc. - Overview

Annual Reports and Proxy. EnteroMedics Inc. (NASDAQ: ETRM) has developed a novel medical device with the potential to advance weight loss treatment and address the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension. EnteroMedics is committed to advancing the scientific, medical and commercial potential of VBLOC vagal blocking therapy, the Companys proprietary neuroblocking technology, to benefit patients, health care providers and ...Aug 6, 2015.

INTERNAL PAGES

enteromedics.com

1

Enteromedics > International > Obesity

http://www.enteromedics.com/international/obesity.asp

Addressing an Unmet Need. Given the limitations of transient and punitive procedures for the treatment of obesity, there continues to be a significant unmet need for a positive and more encouraging option, specifically:. A physiologic obesity treatment that helps patients succeed in their efforts to lose weight and keep it off, while controlling the co-morbidities of their obesity. An option that does not require compromises in safety, nutrition, lifestyle, food choices or anatomy.

2

Enteromedics > Sitemap

http://www.enteromedics.com/sitemap/default.asp

Legal Notices and Disclaimers. Annual Reports and Proxy. 2800 Patton Road - St. Paul, MN 55113 USA. TEL: 651.634.3003. FAX: 651.634.3212. Page Updated: 06/06/2016 11:07:49 AM.

3

Enteromedics > Newsroom > Press Kit

http://www.enteromedics.com/newsroom/press_kit.asp

EnteroMedic's press kit may be used only by press agencies and journalists publishing articles specifically about EnteroMedic's Inc. and its products. 2800 Patton Road - St. Paul, MN 55113 USA. TEL: 651.634.3003. FAX: 651.634.3212. Page Updated: 05/10/2016 03:26:21 PM. Annual Reports and Proxy.

4

Enteromedics > International > VBLOC Maestro® Rechargeable System

http://www.enteromedics.com/international/vbloc_maestro_system.asp

Important Safety Information for Patients. Use of the Maestro Rechargeable System. EnteroMedics has significant experience with vBloc Therapy; more than 600 patients have been implanted with the Maestro System to date, some out to five years. Safety, efficacy and sustained weight loss with vBloc Therapy has been demonstrated in multiple clinical trials. The major components of the Maestro Rechargeable System include:. The Clinician Programmer connects to the Mobile Charger to enable clinicians to customi...

5

Enteromedics > International

http://www.enteromedics.com/international/default.asp

Important Safety Information for Patients. The Maestro Rechargeable System has received CE Mark for the treatment of obesity and Type 2 diabetes mellitus through improved glycemic control, and has been listed on the Australian Register of Therapeutic Goods (ARTG) by the Therapeutic Goods Administration (TGA) for supply in Australia. 2800 Patton Road - St. Paul, MN 55113 USA. TEL: 651.634.3003. FAX: 651.634.3212. Page Updated: 06/06/2016 11:07:47 AM. Annual Reports and Proxy.

UPGRADE TO PREMIUM TO VIEW 14 MORE

TOTAL PAGES IN THIS WEBSITE

19

LINKS TO THIS WEBSITE

ir.enteromedics.com

EnteroMedics® Inc. - Newsroom

http://ir.enteromedics.com/pressroom.cfm

For press inquiries, please contact:. Welcome to the EnteroMedics. Press room. This resource is intended for media professionals and investors who would like to learn more about EnteroMedics and VBLOC. Aug 17, 2016. EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors. Aug 15, 2016. EnteroMedics Announces Publication of 24 Month ReCharge Clinical Study Data in Obesity Surgery. Aug 4, 2016. EnteroMedics Reports Second Quarter 2016 Financial Results. TEL: 651.634.3003.

ir.enteromedics.com

EnteroMedics® Inc. - Overview

http://ir.enteromedics.com/index.cfm

Annual Reports and Proxy. EnteroMedics Inc. (NASDAQ: ETRM) has developed a novel medical device with the potential to advance weight loss treatment and address the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension. EnteroMedics is committed to advancing the scientific, medical and commercial potential of VBLOC vagal blocking therapy, the Companys proprietary neuroblocking technology, to benefit patients, health care providers and ...

ir.enteromedics.com

EnteroMedics® Inc. - Press Releases

http://ir.enteromedics.com/releases.cfm

For press inquiries, please contact:. EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors. Aug 17, 2016. ST PAUL, Minn., Aug. 17, 2016 /PRNewswire/ - EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, today announced the appointment of Gary Blackford to its Board of Directors, effective August 16, 2016. The Company also announce. Aug 15, 2016. Aug 4, 2016.

ir.enteromedics.com

EnteroMedics Reports Second Quarter 2015 Financial Results (NASDAQ:ETRM)

http://ir.enteromedics.com/releasedetail.cfm?ReleaseID=926218

Laquo; Previous Release. Next Release ». August 6, 2015. EnteroMedics Reports Second Quarter 2015 Financial Results. Announces First U.S. Commercial Sales in Quarter Following FDA Approval. Company to Host Conference Call Today, August 6, 2015, at 11:00 AM ET. ST PAUL, Minn. Aug 6, 2015. June 30, 2015. For the three months ended. June 30, 2015. The Company reported its first U.S. sales of. With gross profits totaling. The Company reported a net loss of. And research and development expenses of. We are pl...

ir.enteromedics.com

EnteroMedics® Inc. - Analyst Coverage

http://ir.enteromedics.com/analysts.cfm

Annual Reports and Proxy. Inc is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding EnteroMedics Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of EnteroMedics Inc. or its management. EnteroMedics Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. TEL: 651.634.3003. Annual Reports and Proxy.

ir.enteromedics.com

EnteroMedics® Inc. - Stock Information

http://ir.enteromedics.com/stockquote.cfm

Annual Reports and Proxy. EnteroMedics Inc. (NASDAQ: ETRM). 3:59 PM ET on Aug 26, 2016. Sign up for email alerts. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by NASDAQ OMX, both third party services, and EnteroMedics. Inc does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. TEL: 651.634.3003.

ir.enteromedics.com

EnteroMedics® Inc. - Events & Presentations

http://ir.enteromedics.com/eventdetail.cfm?EventID=163717

Annual Reports and Proxy. Canaccord Genuity 35th Annual Growth Conference. Aug 13, 2015. Back to previous page. 2800 Patton Road - St. Paul, MN 55113 USA. TEL: 651.634.3003. FAX: 651.634.3212. Annual Reports and Proxy.

wibariatrics.com

LAP-BAND® System | Thomas Y. Chua, M.D., F.A.C.S.

http://www.wibariatrics.com/services-list/lapband

Call Us Directly: (414) 281-9665. 4600 W. Loomis Rd., Suite 101, Milwaukee, WI 53220 View Location. RNY Gastric Bypass (Proximal or Distal). Bilio-Pancreatic Diversion (Duodenal Switch Option). The Lap-Band procedure is performed under general anesthesia where 5 small incisions are made in the upper abdomen above the umbilicus. The largest one is about 1 inch wide for the placement of the port. We also place an average of 6 anchoring sutures to prevent the development of slippage. This minimally invasive...

UPGRADE TO PREMIUM TO VIEW 110 MORE

TOTAL LINKS TO THIS WEBSITE

118

OTHER SITES

enterome.com

ENTEROME | Enterome.com

PROGRAMS & PRODUCTS. CONFERENCES & EVENTS. PROGRAMS & PRODUCTS. CONFERENCES & EVENTS. JANUARY 4, 2018 - PRESS RELEASE. Enterome raises 32 million ($38.5 million) in a Series D financing. JANUARY 4, 2018 - PRESS RELEASE. Enterome raises 32 million ($38.5 million) in a Series D financing. ENTEROME TRANSLATE MOLECULAR UNDERSTANDING OF THE ROLE OF THE HUMAN GUT MICROBIOME. TO DELIVER INNOVATIVE PERSONALIZED MEDICINE AND IMPROVE PATIENT HEALTH. CROHN DISEASE and IBD. Current medical treatment of CD consists o...

enterome.fr

Enterome | Bioscience

Look at the Microbiome. 20th IFSO World Congress 2015. Date : 26-29 August 2015. Location : Vienna (Austria). The 3rd Microbiome R&D and Business Collaboration Forum: USA. Date : 10-11 September 2015. Location : San Diego (USA). Enterome is looking for a Bioinformatics Platform Manager. Paris, France 20 April 2015 Enterome is looking for a Bioinformatics Platform Manager See the Job Description. Pierre Belichard interviewed by MedNous in April 2015 issue. 75011 PARIS, FRANCE. 33 (0)1 75 77 27 85.

enteromed.co.uk

Enterosgel UK official site | For effective relief from diarrhoea, indigestion, upset stomach, traveller's tummy, food poisoning, food allergy, IBS

No products in the cart. Total: £0.00. AAD – Antibiotic associated diarrhoea. CRF – Chronic Kidney Disease. ALD – Alcoholic Liver Disease. IBD – Inflammatory Bowel Disease. AAD – Antibiotic associated diarrhoea. CRF – Chronic Kidney Disease. ALD – Alcoholic Liver Disease. IBD – Inflammatory Bowel Disease. AAD – Antibiotic associated diarrhoea. CRF – Chronic Kidney Disease. ALD – Alcoholic Liver Disease. IBD – Inflammatory Bowel Disease. Now available in LLOYDS PHARMACY. Main effects of ENTEROSGEL:. Enter...

enteromed.com

IIS Windows Server

enteromedical.hu

ENTEROSGEL - Méregtelenítés, testfertőtlenítés másképp, mint mások

Ugrás a fő tartalmi területre. Atóniás szorulás és krónikus colitis időseknél. Kozmetikai felhasználás és fogyókúra. Védekezés rotavírus és enterovírus ellen. Terhesség és rosszullét kezeléséhez. CE 1023 Certifikate 25407. BS EN ISO 13485:2003. Egészségügyi Engedélyezési és Közigazgatási Hivatal. Egészségünk a legnagyobb kincsünk, legyen célunk is! ENTEROSGEL - egyedi orvostechnikai eszköz. A szelektív enteroszorbens. Az Ön egészségéért! Most, hogy hódít az ellergia minden formája.

enteromedics.com

Welcome to EnteroMedics

Is the developer of vBloc. Neurometabolic therapy, delivered by a pacemaker-like device called the Maestro. Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc. Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals.

enteromedics.net

enteromedics.net at Directnic

enteromedx.com

Page parking de votre nom de domaine | NAMEBAY.COM

Enregistrer nom de domaine. Transférer nom de domaine. Renouveler nom de domaine. Alerte à la création. FAQ nom de domaine. Ce nom de domaine a été réservé par l’un de nos clients. Ajouter un compte email. Accéder à mon webmail. Devenir revendeur de nom de domaine. Consulter l'actualité de l'industrie des noms de domaine. Ce service de page d'attente vous est proposé par NAMEBAY.COM.

enteromega.com

Welcome to: enteromega.com. This Web page is parked for FREE, courtesy of GoDaddy.com. Is this your domain? Let's turn it into a website! Would you like to buy this. THE domain at THE price. Visit GoDaddy.com for the best values on. Restrictions apply. See website for details.

enteromics.com

EnterOmics - a gate to your Omics world!

We are sorry but our site is under construction. You can still use our projects sites: educational service. But you are able to connect with us by e-mail: kulemin@enteromics.com. EnterOmics is a company which develops omics based models to prevent a variety of common human diseases.

enteromnipotent.wordpress.com

Enter Omnipotence

In today….Zombies? I spend a lot of time during my day reading, or at least I try to. I think it redundant to even suggest the great importance of educating one’s self, and not all of us have the luxury of attending a university or the likes. My goal at Enter Omnipotence is to share with you my knowledge as I accumulate it at the most effective rate I am able. Actually a rather simple concept as well, is it not? I also read about the first “holographic” phone, and while I have no intentions t...Another i...